Strategic Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Strategic Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.91M	Hold	43,546	–	–	0.94%	39
2021 Q3	$2.21M	Buy	43,546 +2,774	+7%	+$145K	1.15%	35
2021 Q2	$2.12M	Sell	40,772 -4,729	-10%	-$222K	1.14%	32
2021 Q1	$2.08M	Hold	45,501	–	–	1.25%	30
2020 Q4	$2.09M	Hold	45,501	–	–	1.28%	33
2020 Q3	$1.77M	Buy	+45,501	New	+$1.75M	1.32%	31

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Strategic Wealth Management's IDNA Position: Q4 2021 in Review

Strategic Wealth Management held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q4 2021 at 43,546 shares worth $1.91M. The position accounts for 0.94% of the portfolio, ranked #39.

Strategic Wealth Management first reported a position in IDNA in Q3 2020 and has held it in 6 quarters since. The position peaked at $2.21M in Q3 2021. 103 funds tracked by Wall St. Rank hold IDNA as of Q4 2021.

Strategic Wealth Management held 43,546 shares of iShares Genomics Immunology and Healthcare ETF worth $1.91M as of Q4 2021.
Strategic Wealth Management left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q4 2021.
iShares Genomics Immunology and Healthcare ETF made up 0.94% of Strategic Wealth Management's portfolio in Q4 2021, its #39 holding.
Strategic Wealth Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and has held it in 6 quarters since.
Strategic Wealth Management's iShares Genomics Immunology and Healthcare ETF position peaked at $2.21M in Q3 2021.
103 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2021.

Based on Strategic Wealth Management's 13F filing for Q4 2021, filed 7 Feb 2022.